Bailard »

Cullinan Oncology shares owned by Bailard

Quarter-by-quarter ownership of Cullinan Oncology (CGEM) shares owned by Bailard from 13F filings

Historical chart of Bailard investment in Cullinan Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cullinan Oncology held by Bailard consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cullinan Oncology by Bailard

Quarter filed Position value Share count Share price at filing
2023-12-31 $110k 11k 10.19
2023-03-31 $113k 11k 10.23
2021-09-30 $217k 9.6k 22.60

More positions owned by Bailard

Microsoft Corporation (MSFT)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Msci Eafe Etf (EFA)
Alphabet Cap Stk Cl A (GOOGL)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard World Fds Inf Tech Etf (VGT)
Spdr Ser Tr Nuveen Blmbrg Mu (TFI)
Gilead Sciences (GILD)
Janus Detroit Str Tr Henderson Mtg (JMBS)
Pimco Etf Tr Inter Mun Bd Act (MUNI)
Visa Com Cl A (V)

View all positions for Bailard

Top funds holding Cullinan Oncology

Blue Owl Capital Holdings
Franklin Resources
BVF
Vanguard Group
Braidwell
American International
Nextech Invest
Citadel Advisors
Dimensional Fund Advisors
Tang Capital Management
Deutsche Bank Aktiengesellschaft
OrbiMed Advisors
Charles Schwab Investment Management
Millennium Management
Hudson Bay Capital Management

View all funds holding Cullinan Oncology